by Market Overview:
Chemiluminescence immunoassay is a method for detecting and quantifying the levels of various substances in biological samples like blood and urine. It utilizes chemiluminescent reactions for producing measurable light as a signal reporting the occurrence of an event like antigen-antibody binding. It offers high sensitivity, accuracy and a wide dynamic range for the quantitative measurement of various biochemical analytes.
Market key trends:
One of the key trends spurring the growth of chemiluminescence immunoassay market is the increasing prevalence of chronic and infectious diseases across the globe. Chemiluminescence immunoassay plays a vital role in the diagnosis and management of various diseases like cancer, arthritis, hepatitis, HIV/AIDS and cardiovascular diseases. It aids in disease screening, monitoring disease progression, and detecting treatment efficacy. Rising geriatric population prone to chronic illnesses is also fueling the demand for chemiluminescence immunoassay. Moreover, ongoing technological advancements improving assay sensitivity, specificity and throughput are boosting the adoption of chemiluminescence immunoassay in clinical settings. Miniaturization of instruments is also making chemiluminescence immunoassay systems more affordable and user-friendly.
Segment Analysis
The global chemiluminescence immunoassay market is segmented into immunoassays and CLISA, microplate instruments, and consumables and accessories. The immunoassays and CLISA segment dominated the market in 2022 and is expected to continue its dominance during the forecast period owing to increasing demand for high-quality diagnostic tests for infectious diseases. Immunoassays combine the specificity of antibodies with sensitive detection of light to provide precise and accurate test results.
Key Takeaways
The Global Chemiluminescence Immunoassay Market Demand is expected to witness high growth, exhibiting CAGR of 8.0% over the forecast period, due to increasing prevalence of infectious and chronic diseases globally.
North America dominated the global market in 2022 and is expected to continue dominating during the forecast period. This is attributed to rising healthcare spending and presence of advanced healthcare facilities in the region. Asia Pacific is expected to exhibit the highest CAGR during the forecast period due to improving healthcare infrastructure and increasing healthcare spending in major Asian countries.
Key players operating in the chemiluminescence immunoassay market are DiaSorin S.p.A., Abbott Laboratories, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers, Beckman Coulter Inc., F. Hoffmann-La Roche AG, Inova Diagnostics, Inc., Maccura Biotechnology Co., Ltd., Tosoh Corporation, and Ortho Clinical Diagnostic. These players are focusing on new product launches and geographic expansion to strengthen their market position.
Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
